Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Nephrology And Urology Devices Market, By Product
7.1. Nephrology And Urology Devices Market, by Product Type, 2020-2030
7.1.1. Ureteral Catheters
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. PCN Catheters
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Urinary Stents
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Stone Basket
7.1.4.1. Market Revenue and Forecast (2016-2030)
7.1.5. Urology Guidewires
7.1.5.1. Market Revenue and Forecast (2016-2030)
7.1.6. Renal Dilators
7.1.6.1. Market Revenue and Forecast (2016-2030)
7.1.7. Others
7.1.7.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Nephrology And Urology Devices Market, Regional Estimates and Trend Forecast
8.1. North America
8.1.1. Market Revenue and Forecast, by Product (2016-2030)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, by Product (2016-2030)
8.2. Europe
8.2.1. Market Revenue and Forecast, by Product (2016-2030)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, by Product (2016-2030)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, by Product (2016-2030)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, by Product (2016-2030)
8.3. APAC
8.3.1. Market Revenue and Forecast, by Product (2016-2030)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, by Product (2016-2030)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, by Product (2016-2030)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, by Product (2016-2030)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, by Product (2016-2030)
8.4. MEA
8.4.1. Market Revenue and Forecast, by Product (2016-2030)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, by Product (2016-2030)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, by Product (2016-2030)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, by Product (2016-2030)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, by Product (2016-2030)
8.5. Latin America
8.5.1. Market Revenue and Forecast, by Product (2016-2030)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, by Product (2016-2030)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, by Product (2016-2030)
Chapter 9. Company Profiles
9.1. Medtronic plc
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Fresenius Medical Care AG & Co. KGaA
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. Baxter International, Inc.
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Boston Scientific Corp.
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. C.R. Bard, Inc.
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Cook Group, Inc.
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. Hollister, Inc.
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. Nipro Corp.
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.9. Terumo Corp.
9.9.1. Company Overview
9.9.2. Product Offerings
9.9.3. Financial Performance
9.10. Coloplast A/S
9.10.1. Company Overview
9.10.2. Product Offerings
9.10.3. Financial Performance
9.11. ConvaTec Group plc
9.11.1. Company Overview
9.11.2. Product Offerings
9.11.3. Financial Performance
9.12. B. Braun AG
9.12.1. Company Overview
9.12.2. Product Offerings
9.12.3. Financial Performance
9.13. Teleflex, Inc.
9.13.1. Company Overview
9.13.2. Product Offerings
9.13.3. Financial Performance
9.14. Asahi Kasei Corp.
9.14.1. Company Overview
9.14.2. Product Offerings
9.14.3. Financial Performance
9.15. Nxstage Medical, Inc.
9.15.1. Company Overview
9.15.2. Product Offerings
9.15.3. Financial Performance
9.15.4. Recent Initiatives
Chapter 10. Research Methodology
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
Chapter 11. Appendix
11.1. About Us
Glossary of Terms